STRS Ohio’s NexImmune, Inc. Common Stock NEXI Stock Holding History

STRS Ohio’s Portfolio NEXI Stock Details NEXI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-60	Closed	-$6K	–	2346
2022 Q1	$6K	Hold	60	–	–	﹤0.01%	2109
2021 Q4	$6K	Hold	60	–	–	﹤0.01%	2162
2021 Q3	$22K	Hold	60	–	–	﹤0.01%	2182
2021 Q2	$24K	Hold	60	–	–	﹤0.01%	2170
2021 Q1	$28K	Buy	+60	New	+$32.7K	﹤0.01%	2090

Other funds holding NEXI

ACH

ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return

Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return

SPC

Slate Path Capital New York $6.73B AUM 95.97% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

Allen Operations New York $670M AUM 26.43% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Bridger Management New York $128M AUM 9.54% 1-Year Est. Return

ECG

EPIQ Capital Group San Francisco, California $383M AUM 46.87% 1-Year Est. Return

KHCM

Kettle Hill Capital Management New York $399M AUM 10.05% 1-Year Est. Return

STRS Ohio's NEXI Position: Q2 2022 in Review

STRS Ohio sold out of NexImmune, Inc. Common Stock (NEXI) in Q2 2022, closing a stake of 60 shares — an estimated $6K sold.

STRS Ohio first reported a position in NEXI in Q1 2021 and held it in 5 quarters. The position peaked at $28K in Q1 2021. 44 funds tracked by Wall St. Rank hold NEXI as of Q2 2022.

STRS Ohio reported no remaining NexImmune, Inc. Common Stock position as of Q2 2022 after selling out during the quarter.
STRS Ohio sold 60 NexImmune, Inc. Common Stock shares in Q2 2022, an estimated $6K.
STRS Ohio first reported a position in NexImmune, Inc. Common Stock in Q1 2021 and held it in 5 quarters.
STRS Ohio's NexImmune, Inc. Common Stock position peaked at $28K in Q1 2021.
44 funds tracked by Wall St. Rank held NexImmune, Inc. Common Stock as of Q2 2022.

Based on STRS Ohio's 13F filing for Q2 2022, filed 25 Jul 2022.